Abstract
Embryonic stem cells (ESCs) are pluripotent stem cells that can be obtained from the inner cell mass (ICM) of blastocyst-stage pre-implantation embryos. The first lines of human ESC (hESC) were derived by Thomson et al. in 1998. These cells can be indefinitely cultured in vitro and differentiated into different cell types. These cell lines constitute an excellent source of cells for the study of human genetics and gene expression patterns and as a tool to understand the events that take place during human embryo development. These cell lines can also be useful for drug screening and for the disease modelling. In 2006, Takahashi and Yamanaka first introduced the technology of induced reprogramming to pluripotency in the mouse and later in human cells. These induced pluripotent stem cells (iPSCs) are generated through the reprogramming of somatic cells back to an embryonic-like state. The reprogramming process is induced by the addition of exogenous reprogramming factors. Human iPSC (hiPSC) technology avoids the destruction of human embryos and the ethical debate involved. Moreover, patient-specific iPSC can be obtained by this technology providing unprecedented opportunities, not only in regenerative medicine but also in basic research as disease models, drug discovery and toxicology. The emerging demands of stem cell research and applications require the establishment and cooperation of centralized banks at a translational and even global scale. This will ensure the availability of high-quality hPSC using standardized state-of-the-art methods and strategies to deal with a heterogeneous regulatory, ethical and legal landscape. Furthermore, stem cell banks are essential for the distribution of cell lines among research centres, promoting scientific collaboration and facilitating widespread use of the cells for research and clinical applications.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aasen T, Raya A, Barrero MJ, Garreta E, Consiglio A, Gonzalez F et al (2008) Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 26(11):1276–1284
Allegrucci C, Young LE (2007) Differences between human embryonic stem cell lines. Hum Reprod Update 13(2):103–120
Amit M, Shariki C, Margulets V, Itskovitz-Eldor J (2004) Feeder layer- and serum-free culture of human embryonic stem cells. Biol Reprod 70(3):837–845
Andrews PW, Baker D, Benvinisty N, Miranda B, Bruce K, Brustle O et al (2015) Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI). Regen Med 10(2 Suppl):1–44
Aran B, Rodriguez-Piza I, Raya A, Consiglio A, Munoz Y, Barri PN et al (2010) Derivation of human embryonic stem cells at the Center of Regenerative Medicine in Barcelona. In Vitro Cell Dev Biol Anim 46(3–4):356–366
Avior Y, Sagi I, Benvenisty N (2016) Pluripotent stem cells in disease modelling and drug discovery. Nat Rev Mol Cell Biol 17(3):170–182
Baghbaderani BA, Tian X, Neo BH, Burkall A, Dimezzo T, Sierra G et al (2015) cGMP-manufactured human induced pluripotent stem cells are available for pre-clinical and clinical applications. Stem Cell Rep 5(4):647–659
Bellin M, Marchetto MC, Gage FH, Mummery CL (2012) Induced pluripotent stem cells: the new patient? Nat Rev Mol Cell Biol 13(11):713–726
Bongso A, Fong CY, Ng SC, Ratnam S (1994) Isolation and culture of inner cell mass cells from human blastocysts. Hum Reprod 9(11):2110–2117
Borstlap J, Luong MX, Rooke HM, Aran B, Damaschun A, Elstner A et al (2010) International stem cell registries. In Vitro Cell Dev Biol Anim 46(3–4):242–246
Borstlap J, Stacey G, Kurtz A, Elstner A, Damaschun A, Aran B et al (2008) First evaluation of the European hESCreg. Nat Biotechnol 26(8):859–860
Bradley JA, Bolton EM, Pedersen RA (2002) Stem cell medicine encounters the immune system. Nat Rev Immunol 2(11):859–871
Brennand KJ, Simone A, Jou J, Gelboin-Burkhart C, Tran N, Sangar S et al (2011) Modelling schizophrenia using human induced pluripotent stem cells. Nature 473(7346):221–225
Brito A, Russo FB, Muotri AR, Beltrao-Braga PCB. Autism spectrum disorders and disease modeling using stem cells. Cell Tissue Res 2018;371(1):153–60
Chen AE, Egli D, Niakan K, Deng J, Akutsu H, Yamaki M et al (2009) Optimal timing of inner cell mass isolation increases the efficiency of human embryonic stem cell derivation and allows generation of sibling cell lines. Cell Stem Cell 4(2):103–106
Chou BK, Mali P, Huang X, Ye Z, Dowey SN, Resar LM et al (2011) Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures. Cell Res 21(3):518–529
Crook JM, Hei D, Stacey G (2010) The International Stem Cell Banking Initiative (ISCBI): raising standards to bank on. In Vitro Cell Dev Biol Anim 46(3–4):169–172
Crook JM, Peura TT, Kravets L, Bosman AG, Buzzard JJ, Horne R et al (2007) The generation of six clinical-grade human embryonic stem cell lines. Cell Stem Cell 1(5):490–494
De Sousa PA, Downie JM, Tye BJ, Bruce K, Dand P, Dhanjal S et al (2016) Development and production of good manufacturing practice grade human embryonic stem cell lines as source material for clinical application. Stem Cell Res 17(2):379–390
Devine MJ, Ryten M, Vodicka P, Thomson AJ, Burdon T, Houlden H et al (2011) Parkinson's disease induced pluripotent stem cells with triplication of the alpha-synuclein locus. Nat Commun 2:440
DiStefano T, Chen HY, Panebianco C, Kaya KD, Brooks MJ, Gieser L, et al. Accelerated and Improved differentiation of retinal organoids from pluripotent stem cells in Rotating-Wall vessel bioreactors. Stem cell reports. 2018;10(1):300–13
Dowey SN, Huang X, Chou BK, Ye Z, Cheng L (2012) Generation of integration-free human induced pluripotent stem cells from postnatal blood mononuclear cells by plasmid vector expression. Nat Protoc 7(11):2013–2021
Drukker M, Katchman H, Katz G, Even-Tov Friedman S, Shezen E, Hornstein E et al (2006) Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells 24(2):221–229
Durruthy-Durruthy J, Briggs SF, Awe J, Ramathal CY, Karumbayaram S, Lee PC et al (2014) Rapid and efficient conversion of integration-free human induced pluripotent stem cells to GMP-grade culture conditions. PLoS One 9(4):e94231
Ellerstrom C, Strehl R, Moya K, Andersson K, Bergh C, Lundin K et al (2006) Derivation of a xeno-free human embryonic stem cell line. Stem Cells 24(10):2170–2176
Fusaki N, Ban H, Nishiyama A, Saeki K, Hasegawa M (2009) Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci 85(8):348–362
Genbacev O, Krtolica A, Zdravkovic T, Brunette E, Powell S, Nath A et al (2005) Serum-free derivation of human embryonic stem cell lines on human placental fibroblast feeders. Fertil Steril 83(5):1517–1529
Giorgetti A, Montserrat N, Aasen T, Gonzalez F, Rodriguez-Piza I, Vassena R et al (2009) Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. Cell Stem Cell 5(4):353–357
Gourraud PA, Hollenbach JA, Barnetche T, Single RM, Mack SJ (2012) Standard methods for the management of immunogenetic data. Methods Mol Biol 882:197–213
Gymrek M, McGuire AL, Golan D, Halperin E, Erlich Y (2013) Identifying personal genomes by surname inference. Science 339(6117):321–324
Haidet-Phillips AM, Hester ME, Miranda CJ, Meyer K, Braun L, Frakes A et al (2011) Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat Biotechnol 29(9):824–828
Hasegawa K, Pomeroy JE, Pera MF (2010) Current technology for the derivation of pluripotent stem cell lines from human embryos. Cell Stem Cell 6(6):521–531
Heins N, Englund MC, Sjoblom C, Dahl U, Tonning A, Bergh C et al (2004) Derivation, characterization, and differentiation of human embryonic stem cells. Stem Cells 22(3):367–376
Imaizumi K, Nishishita N, Muramatsu M, Yamamoto T, Takenaka C, Kawamata S et al (2014) A simple and highly effective method for slow-freezing human pluripotent stem cells using dimethyl sulfoxide, hydroxyethyl starch and ethylene glycol. PLoS One 9(2):e88696
International Stem Cell Banking I (2009) Consensus guidance for banking and supply of human embryonic stem cell lines for research purposes. Stem Cell Rev 5(4):301–314
International Stem Cell I, Adewumi O, Aflatoonian B, Ahrlund-Richter L, Amit M, Andrews PW et al (2007) Characterization of human embryonic stem cell lines by the international stem cell initiative. Nat Biotechnol 25(7):803–816
Isasi RM, Knoppers BM (2009) Governing stem cell banks and registries: emerging issues. Stem Cell Res 3(2–3):96–105
Kim D, Kim CH, Moon JI, Chung YG, Chang MY, Han BS et al (2009) Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4(6):472–476
Kim JH, Kurtz A, Yuan BZ, Zeng F, Lomax G, Loring JF et al (2017) Report of the international stem cell banking initiative workshop activity: current hurdles and progress in seed-stock banking of human pluripotent stem cells. Stem Cells Transl Med 6(11):1956–1962
Kimbrel EA, Lanza R (2016) Pluripotent stem cells: the last 10 years. Regen Med 11(8):831–847
Klimanskaya I, Chung Y, Becker S, Lu SJ, Lanza R (2006) Human embryonic stem cell lines derived from single blastomeres. Nature 444(7118):481–485
Klimanskaya I, Chung Y, Meisner L, Johnson J, West MD, Lanza R (2005) Human embryonic stem cells derived without feeder cells. Lancet 365(9471):1636–1641
Knoppers BM, Isasi R (2010) Stem cell banking: between traceability and identifiability. Genome Med 2(10):73
Knoppers BM, Isasi R, Benvenisty N, Kim OJ, Lomax G, Morris C et al (2011) Publishing SNP genotypes of human embryonic stem cell lines: policy statement of the international stem cell forum ethics working party. Stem Cell Rev 7(3):482–484
Kondo T, Asai M, Tsukita K, Kutoku Y, Ohsawa Y, Sunada Y et al (2013) Modeling Alzheimer’s disease with iPSCs reveals stress phenotypes associated with intracellular Abeta and differential drug responsiveness. Cell Stem Cell 12(4):487–496
Kucia M, Halasa M, Wysoczynski M, Baskiewicz-Masiuk M, Moldenhawer S, Zuba-Surma E et al (2007) Morphological and molecular characterization of novel population of CXCR4+ SSEA-4+ Oct-4+ very small embryonic-like cells purified from human cord blood: preliminary report. Leukemia 21(2):297–303
Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C et al (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat Genet 45(12):1452–1458
Lancaster MA, Knoblich JA (2014) Generation of cerebral organoids from human pluripotent stem cells. Nat Protoc 9(10):2329–2340
Laustriat D, Gide J, Peschanski M (2010) Human pluripotent stem cells in drug discovery and predictive toxicology. Biochem Soc Trans 38(4):1051–1057
Lerou PH, Yabuuchi A, Huo H, Takeuchi A, Shea J, Cimini T et al (2008) Human embryonic stem cell derivation from poor-quality embryos. Nat Biotechnol 26(2):212–214
Li T, Zhou C, Liu C, Mai Q, Zhuang G (2008) Bulk vitrification of human embryonic stem cells. Hum Reprod 23(2):358–364
Li T, Zhou CQ, Mai QY, Zhuang GL (2005) Establishment of human embryonic stem cell line from gamete donors. Chin Med J 118(2):116–122
Li Y, Tan JC, Li LS (2010) Comparison of three methods for cryopreservation of human embryonic stem cells. Fertil Steril 93(3):999–1005
Loser P, Schirm J, Guhr A, Wobus AM, Kurtz A (2010) Human embryonic stem cell lines and their use in international research. Stem Cells 28(2):240–246
Lu J, Hou R, Booth CJ, Yang SH, Snyder M (2006) Defined culture conditions of human embryonic stem cells. Proc Natl Acad Sci U S A 103(15):5688–5693
Ludwig T, J AT. Defined, feeder-independent medium for human embryonic stem cell culture. Current protocols in stem cell biology. 2007;Chapter 1:Unit 1C 2
Ludwig TE, Levenstein ME, Jones JM, Berggren WT, Mitchen ER, Frane JL et al (2006) Derivation of human embryonic stem cells in defined conditions. Nat Biotechnol 24(2):185–187
Mandai M, Watanabe A, Kurimoto Y, Hirami Y, Morinaga C, Daimon T et al (2017) Autologous induced stem-cell-derived retinal cells for macular degeneration. N Engl J Med 376(11):1038–1046
Marti M, Mulero L, Pardo C, Morera C, Carrio M, Laricchia-Robbio L et al (2013) Characterization of pluripotent stem cells. Nat Protoc 8(2):223–253
McCracken KW, Cata EM, Crawford CM, Sinagoga KL, Schumacher M, Rockich BE et al (2014) Modelling human development and disease in pluripotent stem-cell-derived gastric organoids. Nature 516(7531):400–404
Menasche P, Vanneaux V, Hagege A, Bel A, Cholley B, Cacciapuoti I et al (2015) Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report. Eur Heart J 36(30):2011–2017
Merling RK, Sweeney CL, Choi U, De Ravin SS, Myers TG, Otaizo-Carrasquero F, et al. Transgene-free iPSCs generated from small volume peripheral blood nonmobilized CD34+ cells. Blood 2013;121(14):e98–107
Miller JD, Ganat YM, Kishinevsky S, Bowman RL, Liu B, Tu EY et al (2013) Human iPSC-based modeling of late-onset disease via progerin-induced aging. Cell Stem Cell 13(6):691–705
Mitalipova M, Calhoun J, Shin S, Wininger D, Schulz T, Noggle S et al (2003) Human embryonic stem cell lines derived from discarded embryos. Stem Cells 21(5):521–526
Moretti A, Bellin M, Welling A, Jung CB, Lam JT, Bott-Flugel L et al (2010) Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N Engl J Med 363(15):1397–1409
Murdoch A, Braude P, Courtney A, Brison D, Hunt C, Lawford-Davies J et al (2012) The procurement of cells for the derivation of human embryonic stem cell lines for therapeutic use: recommendations for good practice. Stem Cell Rev 8(1):91–99
Nagai M, Re DB, Nagata T, Chalazonitis A, Jessell TM, Wichterle H et al (2007) Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci 10(5):615–622
Nakatsuji N, Nakajima F, Tokunaga K (2008) HLA-haplotype banking and iPS cells. Nat Biotechnol 26(7):739–740
Nguyen HN, Byers B, Cord B, Shcheglovitov A, Byrne J, Gujar P et al (2011) LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell 8(3):267–280
Ohmine S, Dietz AB, Deeds MC, Hartjes KA, Miller DR, Thatava T et al (2011) Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells. Stem Cell Res Ther 2(6):46
Okita K, Matsumura Y, Sato Y, Okada A, Morizane A, Okamoto S et al (2011a) A more efficient method to generate integration-free human iPS cells. Nat Methods 8(5):409–412
Okita K, Nagata N, Yamanaka S (2011b) Immunogenicity of induced pluripotent stem cells. Circ Res 109(7):720–721
Ota A, Matsumura K, Lee JJ, Sumi S, Hyon SH (2017) StemCell keep is effective for cryopreservation of human embryonic stem cells by vitrification. Cell Transplant 26(5):773–787
Pera MF, Trounson AO (2004) Human embryonic stem cells: prospects for development. Development 131(22):5515–5525
Pistollato F, Bremer-Hoffmann S, Healy L, Young L, Stacey G (2012) Standardization of pluripotent stem cell cultures for toxicity testing. Expert Opin Drug Metab Toxicol 8(2):239–257
Rajala K, Hakala H, Panula S, Aivio S, Pihlajamaki H, Suuronen R et al (2007) Testing of nine different xeno-free culture media for human embryonic stem cell cultures. Hum Reprod 22(5):1231–1238
Raya A, Rodriguez-Piza I, Aran B, Consiglio A, Barri PN, Veiga A et al (2008) Generation of cardiomyocytes from new human embryonic stem cell lines derived from poor-quality blastocysts. Cold Spring Harb Symp Quant Biol 73:127–135
Reubinoff BE, Pera MF, Fong CY, Trounson A, Bongso A (2000) Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol 18(4):399–404
Reubinoff BE, Pera MF, Vajta G, Trounson AO (2001) Effective cryopreservation of human embryonic stem cells by the open pulled straw vitrification method. Hum Reprod 16(10):2187–2194
Richards M, Fong CY, Chan WK, Wong PC, Bongso A (2002) Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells. Nat Biotechnol 20(9):933–936
Rodin S, Domogatskaya A, Strom S, Hansson EM, Chien KR, Inzunza J et al (2010) Long-term self-renewal of human pluripotent stem cells on human recombinant laminin-511. Nat Biotechnol 28(6):611–615
Sanchez-Danes A, Richaud-Patin Y, Carballo-Carbajal I, Jimenez-Delgado S, Caig C, Mora S et al (2012) Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson’s disease. EMBO Mol Med 4(5):380–395
Santos DM, Tiscornia G (2017) Induced pluripotent stem cell modeling of Gaucher’s disease: what have we learned? Int J Mol Sci 18(4):888
Schwartz SD, Hubschman JP, Heilwell G, Franco-Cardenas V, Pan CK, Ostrick RM et al (2012) Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 379(9817):713–720
Schwartz SD, Regillo CD, Lam BL, Eliott D, Rosenfeld PJ, Gregori NZ et al (2015) Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies. Lancet 385(9967):509–516
Seltmann S, Lekschas F, Muller R, Stachelscheid H, Bittner MS, Zhang W et al (2016) hPSCreg–the human pluripotent stem cell registry. Nucleic Acids Res 44(D1):D757–D763
Shi Y, Inoue H, Wu JC, Yamanaka S (2017) Induced pluripotent stem cell technology: a decade of progress. Nat Rev Drug Discov 16(2):115–130
Silva M, Daheron L, Hurley H, Bure K, Barker R, Carr AJ et al (2015) Generating iPSCs: translating cell reprogramming science into scalable and robust biomanufacturing strategies. Cell Stem Cell 16(1):13–17
Sjogren A, Hardarson T, Andersson K, Caisander G, Lundquist M, Wikland M et al (2004) Human blastocysts for the development of embryonic stem cells. Reprod Biomed Online 9(3):326–329
Soldner F, Stelzer Y, Shivalila CS, Abraham BJ, Latourelle JC, Barrasa MI et al (2016) Parkinson-associated risk variant in distal enhancer of alpha-synuclein modulates target gene expression. Nature 533(7601):95–99
Song WK, Park KM, Kim HJ, Lee JH, Choi J, Chong SY et al (2015) Treatment of macular degeneration using embryonic stem cell-derived retinal pigment epithelium: preliminary results in Asian patients. Stem Cell Rep 4(5):860–872
Stacey GN, Crook JM, Hei D, Ludwig T (2013) Banking human induced pluripotent stem cells: lessons learned from embryonic stem cells? Cell Stem Cell 13(4):385–388
Strelchenko N, Verlinsky O, Kukharenko V, Verlinsky Y (2004) Morula-derived human embryonic stem cells. Reprod Biomed Online 9(6):623–629
Strom S, Inzunza J, Grinnemo KH, Holmberg K, Matilainen E, Stromberg AM et al (2007) Mechanical isolation of the inner cell mass is effective in derivation of new human embryonic stem cell lines. Hum Reprod 22(12):3051–3058
Sun N, Yazawa M, Liu J, Han L, Sanchez-Freire V, Abilez OJ et al (2012) Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy. Sci Transl Med 4(130):130ra47
Takahashi Y, Sato S, Kurashima Y, Yamamoto T, Kurokawa S, Yuki Y, Takemura N, Uematsu S, Lai C-Y, Otsu M, Matsuno H, Osawa H, Mizushima T, Nishimura J, Hayashi M, Yamaguchi T, Kiyono H (2018) A refined culture system for human induced pluripotent stem cell-derived intestinal epithelial organoids. Stem Cell Reports 10(1):314–328
Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K et al (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5):861–872
Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663–676
Takebe T, Sekine K, Enomura M, Koike H, Kimura M, Ogaeri T et al (2013) Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature 499(7459):481–484
Tannenbaum SE, Turetsky TT, Singer O, Aizenman E, Kirshberg S, Ilouz N et al (2012) Derivation of xeno-free and GMP-grade human embryonic stem cells–platforms for future clinical applications. PLoS One 7(6):e35325
Taylor CJ, Bolton EM, Pocock S, Sharples LD, Pedersen RA, Bradley JA (2005) Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching. Lancet 366(9502):2019–2025
Taylor CJ, Peacock S, Chaudhry AN, Bradley JA, Bolton EM (2012) Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types. Cell Stem Cell 11(2):147–152
Tedder RS, Zuckerman MA, Goldstone AH, Hawkins AE, Fielding A, Briggs EM et al (1995) Hepatitis B transmission from contaminated cryopreservation tank. Lancet 346(8968):137–140
Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS et al (1998) Embryonic stem cell lines derived from human blastocysts. Science 282(5391):1145–1147
Turetsky T, Aizenman E, Gil Y, Weinberg N, Shufaro Y, Revel A et al (2008) Laser-assisted derivation of human embryonic stem cell lines from IVF embryos after preimplantation genetic diagnosis. Hum Reprod 23(1):46–53
Turner M, Leslie S, Martin NG, Peschanski M, Rao M, Taylor CJ et al (2013) Toward the development of a global induced pluripotent stem cell library. Cell Stem Cell 13(4):382–384
Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, Lau F et al (2010) Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7(5):618–630
Wen Z, Nguyen HN, Guo Z, Lalli MA, Wang X, Su Y et al (2014) Synaptic dysregulation in a human iPS cell model of mental disorders. Nature 515(7527):414–418
Woltjen K, Michael IP, Mohseni P, Desai R, Mileikovsky M, Hamalainen R et al (2009) piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458(7239):766–770
Wong KG, Ryan SD, Ramnarine K, Rosen SA, Mann SE, Kulick A et al (2017) CryoPause: a new method to immediately initiate experiments after cryopreservation of pluripotent stem cells. Stem Cell Rep 9(1):355–365
Young JE, Boulanger-Weill J, Williams DA, Woodruff G, Buen F, Revilla AC et al (2015) Elucidating molecular phenotypes caused by the SORL1 Alzheimer’s disease genetic risk factor using human induced pluripotent stem cells. Cell Stem Cell 16(4):373–385
Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II, Thomson JA (2009) Human induced pluripotent stem cells free of vector and transgene sequences. Science 324(5928):797–801
Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S et al (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318(5858):1917–1920
Zhang X, Stojkovic P, Przyborski S, Cooke M, Armstrong L, Lako M et al (2006) Derivation of human embryonic stem cells from developing and arrested embryos. Stem Cells 24(12):2669–2676
Zhou T, Benda C, Dunzinger S, Huang Y, Ho JC, Yang J et al (2012) Generation of human induced pluripotent stem cells from urine samples. Nat Protoc 7(12):2080–2089
Reinhardt P, Schmid B, Burbulla LF, Schöndorf DC, Wagner L, Glatza M, Höing S, Hargus G, Heck SA, Dhingra A, Wu G, Müller S, Brockmann K, Kluba T, Maisel M, Krüger R, Berg D, Tsytsyura Y, Thiel CS, Psathaki OE, Klingauf J, Kuhlmann T, Klewin M, Müller H, Gasser T, Schöler HR, Sterneckert J (2013) Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression. Cell Stem Cell 12(3):354–367. doi: 10.1016/j.stem.2013.01.008
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Aran, B., Raya, Á., Veiga, A. (2018). Pluripotent Stem Cell Banks. In: Delgado-Morales, R. (eds) Stem Cell Genetics for Biomedical Research. Springer, Cham. https://doi.org/10.1007/978-3-319-90695-9_14
Download citation
DOI: https://doi.org/10.1007/978-3-319-90695-9_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-90694-2
Online ISBN: 978-3-319-90695-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)